Intervention

Metformin Extended Release Oral Tablet

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions8

Lead sponsors shown4

Clinical trials

4 shown

Metformin Use to Reduce Disparities in Newly Diagnosed Breast CancerNCT04741204 · 2022-09-01

A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.NCT05571319 · 2022-08-11

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist StudyNCT04409795 · 2021-08-26

Tolerance & Responsiveness Improvement for Metformin (TRIM)NCT03670043 · 2019-03-19

Common conditions

Breast Cancer Stage1 HIV Seropositivity1 Insulin Resistance1 Metabolic Syndrome1 Monogenic Diabetes1 Racial Bias1 Type 1 Diabetes1 Type2 Diabetes Mellitus1

Leading sponsors

Joslin Diabetes Center1 University of Stellenbosch1 West Side Institute for Science and Education1 Woman's1

Trial status mix

COMPLETED3

WITHDRAWN1

Phase mix

PHASE22

PHASE42

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.